The effect of antineoplastic drugs on the pharmacokinetics of antipyrine in the rat.
The pharmacokinetics of antipyrine was investigated in individual rats pretreated with cyclophosphamide, 5-fluorouracil and methotrexate. Before oral dosing a complete emptying of the rat stomach was obtained by 24 hours of fasting and prevention of coprophagy. Antipyrine was given intravenously via a cannula in an inguinal vein and repeated samples of blood were drawn from a cannula in an inguinal artery. Systemic availability of oral antipyrine was studied in rats given the 14C-labelled drug intravenously and the 3H-labelled drug orally after pretreatment with cyclophosphamide. The log plasma concentration versus time curve of antipyrine given orally showed a short absorption and distribution phase followed by a linear elimination phase. Peak antipyrine concentrations were reached 3-6 minutes after oral dosing in control rats. The rate of absorption of antipyrine was moderately decreased by methotrexate. All drugs increased the area under the curve (AUC) of antipyrine. The systemic availability of oral antipyrine after cyclophosphamide pretreatment (0.88) was not changed, but the metabolic clearance of the drug was reduced. The apparent elimination rate constant was decreased by methotrexate and the apparent volume of distribution was decreased by cyclophosphamide and 5-fluorouracil. The results indicate that antineoplastic agents may change drug kinetics in different ways in rats.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000983:Antipyrine / Q000378:metabolism*; D001682:Biological Availability; D001835:Body Weight / Q000187:drug effects; D004347:Drug Interactions; D007700:Kinetics; D008297:Male; D009929:Organ Size / Q000187:drug effects; D051381:Rats
D000970:Antineoplastic Agents; D000983:Antipyrine